Join
Live feed
·
INSIDERFilingvia Quantisnow
Humacyte Inc. logo

Director Sebelius Kathleen bought $50,000 worth of shares (56,818 units at $0.88), increasing direct ownership by 62% to 148,025 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
HUMA· Humacyte Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HUMA (Humacyte Inc.) and more on Quantisnow.